Doreen M. Agnese
Biochemistry, Genetics and Molecular Biology · The Ohio State University
Publications
140
Citations
9,025
Est. group size
~19
Recurring co-author estimate
Active years
31
Publishing since 1996
Doreen M. Agnese's work centers on the surgical management of breast cancer, including risk assessment, genetic testing (such as BRCA1/2 mutations), and treatment options like mastectomy, radiation, and reconstruction. Her research also touches on melanoma surgery, sentinel lymph node biopsy, and the development of clinical practice guidelines that shape how breast cancer patients are treated. Much of this work involves collaborative, multi-institutional efforts and contributes to national guidelines used by oncologists and surgeons.
Publication output has remained fairly steady over the last decade, fluctuating between roughly 5 and 11 papers per year without a clear upward or downward trend.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Breast Surgical Perspectives on the NSABP B-51/RTOG 1304 Trial on Omission of Regional Nodal Irradiation After Response to Neoadjuvant Chemotherapy
Annals of Surgical Oncology · 2026
- Abstract PS1-07-24: External beam accelerated partial breast irradiation versus whole breast irradiation for invasive lobular carcinoma: a retrospective, single-institution study
Clinical Cancer Research · 2026
- Surgical Perspective on the Updated American College of Radiology Supplemental Screening Guidelines for Breast Density
Annals of Surgical Oncology · 2026
- Commentary and Updates on the Management of Male Breast Cancer
Annals of Surgical Oncology · 2025
- Society of Surgical Oncology Breast Disease Site Working Group Statement on Contralateral Mastectomy: Indications, Outcomes, and Risks
Annals of Surgical Oncology · 2024
- Society of Surgical Oncology Breast Disease Site Working Group Statement on Bilateral Risk-Reducing Mastectomy: Indications, Outcomes, and Risks
Annals of Surgical Oncology · 2024
- Patient-Reported Outcomes for Low-Risk Ductal Carcinoma In Situ
JAMA Oncology · 2024
- Making Informed Choices On Incorporating Chemoprevention into carE (MiCHOICE, SWOG 1904): Design and methods of a cluster randomized controlled trial
Contemporary Clinical Trials · 2024
- Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2022
- Therapeutic Value of Sentinel Lymph Node Biopsy in Patients With Melanoma
JAMA Surgery · 2022
- NCCN Guidelines® Insights: Breast Cancer, Version 4.2021
Journal of the National Comprehensive Cancer Network · 2021
- Concurrent germline BRCA1, BRCA2, and CHEK2 pathogenic variants in hereditary breast cancer: a case series
Breast Cancer Research and Treatment · 2021
- Prospective pilot study protocol evaluating the safety and feasibility of robot-assisted nipple-sparing mastectomy (RNSM)
BMJ Open · 2021
- Adjuvant Radiation Does Not Affect Locoregional Control Following Resection of Melanoma Satellitosis or In-Transit Disease
The American Surgeon · 2021
- Patient Response to Receiving a Notification of Elevated Breast Cancer Risk after Regular Screening Mammogram
Cancer Epidemiology Biomarkers & Prevention · 2021
- Annals of Surgical Oncology×13
- Journal of the National Comprehensive Cancer Network×7
- The Breast Journal×5
- Clinical Cancer Research×5
- Journal of Clinical Oncology×4
- Ashley Pariser
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Benjin D. Facer
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Erin E. Burke
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Stephen P. Povoski
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Ko Un Park
Biochemistry, Genetics and Molecular Biology · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile